Limerston Capital Completes Source BioScience Storage Business Unit Acquisition

Limerston Capital, the UK mid-market private equity investment firm, has completed the acquisition of Source BioScience’s Stability Storage business, underlining its commitment to the healthcare, testing and certification sectors.

Jay LeCoque, Chairman and CEO of Source BioScience, commented: “We believe Limerston is perfectly poised to realise the opportunity for Astoriom to thrive under new leadership whilst allowing Source to focus further investment in its core laboratory services businesses.”

To read the full press release, please click here.